US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
The U.S. Food and Drug Administration approved on Tuesday Amgen's Bkemv, the first biosimilar to AstraZeneca's rare blood ...
Drug Store News3d
FDA approves Amgen's Soliris biosimilar
Amgen’s Bkemv is the first interchangeable biosimilar to Soliris to treat certain rare diseases. The treatment of patients ...
Hosted on MSN21d
FDA approves Amgen's treatment for most deadly form of lung cancer
The Food and Drug Administration on Thursday approved Amgen's treatment for patients with the most deadly form of lung cancer. The agency cleared the drug, called Imdelltra, as a second or later ...
Reuters20d
US FDA approves Amgen drug for small cell lung cancer
May 16 (Reuters) - (This May 16 story has been officially corrected by Amgen to change the pricing estimate in paragraph 4) The U.S. Food and Drug Administration on Thursday granted accelerated ...
The New York Times22d
F.D.A. Approves Drug for Persistently Deadly Form of Lung Cancer
The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year. By Gina Kolata The Food and Drug Administration on Thursday approved an innovative ...
U.S. News & World Report21d
FDA Approves New Drug for Deadly Lung Cancer
FRIDAY, May, 17, 2024 (HealthDay News) -- The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer. Importantly ...
UPI21d
FDA approves Imdelltra for patients with extensive-stage small cell lung cancer
The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer. Importantly, tarlatamab (Imdelltra) is only for patients who ...
Hosted on MSN21d
US FDA approves Amgen drug for small cell lung cancer
US FDA approves Amgen drug for small cell lung ... Results from a mid-stage trial published last year in the New England Journal of Medicine showed that tumors shrank in 40% of patients ...
U.S. News & World Report21d
US FDA Approves Amgen Drug for Small Cell Lung Cancer
US FDA Approves Amgen Drug for Small Cell Lung Cancer (This May 16 story has been officially corrected to change the pricing estimate in paragraph 4) (Reuters) - The U.S. Food and Drug ...